Equillium (EQ) Enterprise Value (2017 - 2026)
Equillium (EQ) reported Enterprise Value of -$60.4 million for Q1 2026, down 316.48% year-over-year from $27.9 million in Q1 2025, and down 103.11% quarter-over-quarter from -$29.7 million in Q4 2025.
Equillium (EQ) Enterprise Value (2017 - 2026) Analysis & Trends
Equillium (EQ) has 10 years of Enterprise Value data on file, last reported at -$60.4 million in Q1 2026.
- Enterprise Value for Q1 2026 came in at -$60.4 million, down 316.48% year-over-year; the trailing twelve-month figure through Mar 2026 was -$60.4 million (down 316.48% YoY), and the FY2025 annual result was -$29.7 million, down 31.71% from the prior year.
- Enterprise Value retreated to -$60.4 million in Q1 2026 per EQ's latest filing, from -$29.7 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$11.5 million in Q2 2025 and troughed at -$71.0 million in Q4 2022.
- A 5-year average of -$41.3 million and a median of -$40.9 million in 2023 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2025 and 2026: Enterprise Value jumped 65.48% in 2025, then slumped 316.48% in 2026.
- A 5-year view of Enterprise Value shows it stood at -$71.0 million in 2022, then surged by 42.46% to -$40.9 million in 2023, then jumped by 44.76% to -$22.6 million in 2024, then tumbled by 31.71% to -$29.7 million in 2025, then sank by 103.11% to -$60.4 million in 2026.
- Business Quant data shows EQ's Enterprise Value at -$60.4 million in Q1 2026, -$29.7 million in Q4 2025, and -$33.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -584.73 Mn |
| 10 | Equillium | 293.17 Mn | 232.78 Mn | - | -60.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -60.39 Mn |
| Dec 31, 2025 | -29.73 Mn |
| Sep 30, 2025 | -33.12 Mn |
| Jun 30, 2025 | -11.50 Mn |
| Mar 31, 2025 | -14.50 Mn |
| Dec 31, 2024 | -22.58 Mn |
| Sep 30, 2024 | -25.88 Mn |
| Jun 30, 2024 | -33.30 Mn |
| Mar 31, 2024 | -32.29 Mn |
| Dec 31, 2023 | -40.87 Mn |
| Sep 30, 2023 | -46.31 Mn |
| Jun 30, 2023 | -48.38 Mn |
| Mar 31, 2023 | -61.99 Mn |
| Dec 31, 2022 | -71.02 Mn |
| Sep 30, 2022 | -44.52 Mn |
| Jun 30, 2022 | -57.56 Mn |
| Mar 31, 2022 | -68.82 Mn |
| Dec 31, 2021 | -80.71 Mn |
| Sep 30, 2021 | -90.69 Mn |
| Jun 30, 2021 | -97.64 Mn |